GlassScriptPhysician profile
Nicholas Anthony Russo
NPI 1487282695
$7,156.65
in general payments reported to CMS, 2019-2025
10 companies · $2,989 in 2025
The $2,989 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,168 · 2025: $2,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,523 · Food and Beverage: $2,059 · Travel and Lodging: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,522.75 |
| Food and Beverage | $2,059.37 |
| Travel and Lodging | $574.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,522.75 | 2024-2025 | Infinity |
| Medtronic, INC. | $1,161.84 | 2024-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Boston Scientific Corporation | $613.82 | 2024-2025 | General - Pain Management |
| Biotronik Nro, INC. | $302.10 | 2024-2025 | Prospera |
| Spr Therapeutics, INC | $229.41 | 2024 | Sprint Pns System |
| Saluda Medical Americas, INC. | $182.30 | 2024-2025 | Evoke |
| Mml US, INC. | $53.57 | 2025 | Reactiv8 |
| Vertex Pharmaceuticals Incorporated | $52.70 | 2024 | |
| Si-Bone, INC. | $23.84 | 2024 | |
| Averitas Pharma INC. | $14.32 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.